CTNM

CONTINEUM THERAPEUTICS INC

CTNM·21217B100·US·Common Stock·Healthcare - Biotechnology-13D/G

CTNM (CONTINEUM THERAPEUTICS INC) is held by 63 institutional investors as of Q2 2026. Largest holders: BlackRock, Inc. ($33.8M), FRANKLIN RESOURCES INC ($30.1M), BALYASNY ASSET MANAGEMENT L.P. ($25M). Net institutional sentiment: Mixed.

63
Holders
(1 Elite)
$237.1M
Total Value
62% (68)
Consensus
42 buying - 26 selling
13F: Insider & Congress: Updated regularly
CTNM

Smart Money Verdict

View all
Loading verdict
Held by 63 funds
1 elite

Who's Trading

Source dates: Price Aug 28, 2026 · Insiders Aug 3, 2026 · Activists Aug 14, 2026 · Congress none

ActivistBALYASNY ASSET MANAGEMENT L.P.BALYASNY ASSET MANAGEMENT L.P.7.1%Aug 14, 2026
InsiderSNStengone Carmine N.Sell $40KAug 3, 2026
ActivistBlackRock, Inc.BlackRock, Inc.6.3%Jul 27, 2026
Checking access…

Top Holders

Checking access…
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Increased
2.1M(+208.5%)$33.8M0.0%+11.89%
47
Unchanged
1.8M$30.1M0.0%+7.58%
0
Decreased
1.5M(-9.7%)$25M0.0%+46.51%
0
Increased
1.3M(+8.8%)$21.7M0.0%+19.14%
31
Increased
1M(+27.6%)$17M0.0%+23.73%
35
Decreased
931,709(-39.3%)$15.3M0.0%+40.07%
0
Increased
693,188(+145.8%)$11.4M0.0%+11.81%
45
Unchanged
669,337$11M1.3%-3.35%
0
Increased
497,255(+61.9%)$8.2M0.0%+20.65%
40
Increased
425,902(+320.5%)$7M0.0%+8.08%
44
Increased
396,354(+13.2%)$6.5M0.0%+18.47%
31
New
328,000$5.4M0.0%+3.84%
37
Increased
277,804(+321.4%)$4.6M0.0%+7.10%
43
Increased
214,082(+48.7%)$3.5M0.0%+19.04%
37
Decreased
182,413(-21.6%)$3M0.0%+25.15%
0
New
180,302$3M0.0%+3.84%
36
Increased
178,673(+198.1%)$2.9M0.0%+8.95%
42
Increased
177,281(+15.2%)$2.9M0.0%+18.18%
30
Increased
150,797(+171.2%)$2.5M0.0%+9.49%
42
Decreased
130,642(-43.3%)$2.1M0.0%+41.97%
0

Showing 1-20 of 73

1 / 4
CTNMCTNMCONTINEUM THERAPEUTICS INC

Other Healthcare stocks held by institutions

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used